
|Articles|July 25, 2018 (Updated: November 15, 2020)
Novartis Partners with SHYFT
Advertisement
SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.
Novartis will use the following SHYFT solutions:
- STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources
- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
3
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5




